- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02108977
Evaluation of Videoconferencing Versus Telephone Genetic Counseling (EVTGC)
Evaluation of Videoconferencing vs Telephone Genetic Counseling Consultations
Study Overview
Status
Intervention / Treatment
Detailed Description
Objectives: This is a Type 1 hybrid pre-implementation study whose specific aims are to: 1) Compare retention of genetic counseling information provided to patients via telephone versus videoconferencing; 2) Use validated surveys to quantitatively assess satisfaction with genetic counseling conducted via telephone versus videoconferencing; 3) Conduct interviews with patients to qualitatively assess positive and negative aspects of their experience, barriers, and facilitators with genetic counseling via telephone or videoconferencing; 4) Conduct interviews with the genetic counselors at Genomic Medicine Service (GMS) to qualitatively assess barriers and facilitators to conducting genetic counseling via telephone and videoconferencing; and 5) Conduct a cost analysis of the telephone and videoconferencing genetic counseling modalities.
Methods: We will undertake a randomized controlled trial of Veterans that are willing to have genetic counseling conducted either via telephone or videoconferencing. Veterans with multiple polyps referred to GMS for genetic counseling will undergo a screening interview by telephone to obtain information about personal and family history and study inclusion and exclusion criteria eligibility. If criteria are met, they will be given information about the study and asked to provide informed consent. If consent is provided, baseline questions will be asked to collect demographic information and assess genetic knowledge. Randomization via random number generation will be used to assign subjects to either the telephone or videoconferencing arms. Lastly, a genetic counseling session will be scheduled for each patient.
Within one week of receiving genetic counseling, participants will be called to assess knowledge retention, conduct the satisfaction surveys and numeracy, and to schedule the qualitative interview for the subset of patients (10-12 per study arm) who agree to participate. We will use the Consolidated Framework for Implementation Research to develop and conduct qualitative interviews with the GMS staff.
Based on power calculation, we will need a sample size of 56 subjects. To achieve this sample size we will need to recruit approximately two to three subjects per week over a seven month period. This requires a reasonable participation rate between 32-40% of polyposis patients referred to GMS for genetic counseling.
Data analysis will begin with descriptive statistics to describe our study sample. To assess differences in knowledge retention and satisfaction between the telephone and videoconferencing groups, we will use Chi-square test for categorical variables and the Wilcoxon-rank sum test for discrete ordinal and continuous variables. We will also conduct multivariable ordinary least squares regression to assess whether knowledge retention or satisfaction differs according to patient characteristics, numeracy, or genetic counselor. The qualitative interviews will be digital audio recorded and transcribed for analysis. We will use a directed approach to content analysis. Analysis will be conducted with Atlas.ti qualitative analysis software that facilitates management of coding and analysis of patterns across transcripts. Cost analysis of the two counseling options will be assessed by direct measurement of equipment and labor input costs as well as travel reimbursement by the VA. From the patient's perspective, the costs associated with traveling to a VA clinic site with videoconferencing equipment will also be considered.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center, Durham, NC
-
-
Utah
-
Salt Lake City, Utah, United States, 84148
- VA Salt Lake City Health Care System, Salt Lake City, UT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 50 or greater,
- a finding of 10 or more lifetime adenomatous polyps or sessile polyps,
- no contributing family history,
- and the patient must be able to be reached by telephone and speak English
Exclusion Criteria:
- Complex family history (family members with other cancers) or one suggestive of a known colon cancer syndrome,
- unwillingness to travel to a VA site with videoconferencing capability,
- diagnosis of colon cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Videoconferencing Genetic Consultation
Patients will travel to CBOC and receive genetic counseling session via videoconferencing
|
Patients will travel to CBOC and receive genetic counseling session via videoconferencing
|
|
Active Comparator: Teleconferencing Genetic Consultation
Patients will receive genetic counseling session via telephone (usual treatment)
|
Patients will receive genetic counseling session via telephone (usual treatment)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Knowledge Retention of Genetic Counseling Information Via 8-Question Pre- and Post-Counseling Assessment
Time Frame: Pre- and post- (within 2 weeks) genetic counseling
|
Subjects will be asked 8 True/False genetics-related questions before and after counseling to assess improvement and retention of genetic counseling knowledge and information
|
Pre- and post- (within 2 weeks) genetic counseling
|
|
Satisfaction With Genetic Counseling Session Using the Genetic Counseling Satisfaction Scale
Time Frame: Within two weeks of receiving genetic counseling
|
6-question Genetic Counseling Satisfaction Scale using 5-point Likert scale responses Strongly Disagree (1) to Strongly Agree (5)
|
Within two weeks of receiving genetic counseling
|
|
Qualitative Assessment of Genetic Counseling Experience, Barriers and Facilitators by PATIENTS
Time Frame: Within six weeks of receiving genetic counseling
|
We asked the subjects to discuss specific aspects of each modality including the ease of use, navigation, and adaptability of each modality, conveying and comprehending genetic and numeric information, and perceived advantages and disadvantages of each modality.
|
Within six weeks of receiving genetic counseling
|
|
Qualitative Assessment of Genetic Counseling Experience, Barriers and Facilitators by GENETIC COUNSELORS
Time Frame: Within 4 weeks after study data collection was completed
|
Five counselors agreed to be interviewed.
We asked them to discuss specific aspects of each modality including the ease of use, navigation, and adaptability of each modality, conveying and comprehending genetic and numeric information, and perceived advantages and disadvantages of each modality.
|
Within 4 weeks after study data collection was completed
|
|
Cost Analysis
Time Frame: Cost analysis will be conducted in months 10-12 of grant period (projected January 1-March 31, 2015)
|
Labor (including training) and non-labor (e.g., equipment cost) inputs required to provide counseling via telephone versus videoconferencing.
Patient travels costs will be included via self-report.
|
Cost analysis will be conducted in months 10-12 of grant period (projected January 1-March 31, 2015)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Santanu K. Datta, PhD, Durham VA Medical Center, Durham, NC
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PPO 13-364
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Remote Consultation, Teleconsultation
-
Centre Hospitalier Universitaire de la GuadeloupeGIRCI SOHORecruitingHeart Failure | Echocardiography, Doppler | Remote Consultation, TeleconsultationGuadeloupe
-
Universitair Ziekenhuis BrusselActive, not recruitingRemote ConsultationBelgium
-
Sha'ar Menashe Mental Health CenterGalil Center for Telemedicine and Medical InformaticsCompletedRemote Consultation [L01.178.847.652.550]Israel
-
US Department of Veterans AffairsJohns Hopkins Bloomberg School of Public Health; Medical College of WisconsinCompletedTelemedicine | Remote Consultation | Patient SatisfactionUnited States
-
Massachusetts General HospitalConquer Cancer FoundationCompletedCancer | Advanced Cancer | Consultation, Remote | Follow-Up CareUnited States
-
Sha'ar Menashe Mental Health CenterGalil Center for Telemedicine and Medical InformaticsUnknownRemote Consultation | Community PsychiatryIsrael
-
Centre Hospitalier Universitaire de NīmesCompletedTelemedicine | Anesthesia | Consultation, RemoteFrance
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedConsultation (LLS) | Consultation and Coaching (HLS)United States
-
Les Entreprises de TélémédecineCompletedTelemedicine | Telehealth | TeleconsultationFrance
-
University Hospital, MontpellierCompleted
Clinical Trials on Videoconferencing Genetic Consultation
-
Philipps University Marburg Medical CenterCompleted
-
Bien-Willner Physicians Group PANo One Left Alone; Carolina Blood and Cancer Care AssociatesNot yet recruitingAdvanced Cancer | Myeloid Malignancy | Solid Tumor, AdultUnited States
-
University of MichiganNational Institute on Aging (NIA)CompletedMild Cognitive ImpairmentUnited States
-
Poitiers University HospitalCompletedPreterm Infants | Parent-Child Relations | Parental Stress | Post Partum Depression | Neonatal Intensive Care Units | VideoconferencingFrance
-
University of AarhusAarhus University Hospital; Central Denmark Region; Prehospital Medical Emergency...Unknown
-
Stanford UniversityCalifornia Breast Cancer Research ProgramCompletedDepression | Breast Cancer | Stress | Breast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast CancerUnited States
-
University of Colorado, DenverCompletedChronic IllnessUnited States
-
University of AarhusAarhus University Hospital; Central Denmark RegionCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH); MainSquare Co. (dba 'Teleo')Not yet recruitingMood Disorders | AnxietyUnited States
-
University of MichiganRecruitingDepression | Anxiety | Post Traumatic Stress DisorderUnited States